BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29387900)

  • 1. [Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy].
    Strobel O; Büchler MW
    Chirurg; 2018 Mar; 89(3):241. PubMed ID: 29387900
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy].
    Strobel O; Büchler MW
    Chirurg; 2019 Mar; 90(Suppl 2):70. PubMed ID: 30758552
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver transplantation for cholangiocarcinoma: current best practice.
    DeOliveira ML
    Curr Opin Organ Transplant; 2014 Jun; 19(3):245-52. PubMed ID: 24811436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growing Evidence Supports the Use of Radiation Therapy in Unresectable Intrahepatic Cholangiocarcinoma.
    Cuneo KC; Lawrence TS
    Cancer J; 2016; 22(4):243-4. PubMed ID: 27441742
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?
    Heimbach JK; Gores GJ; Nagorney DM; Rosen CB
    Surgery; 2006 Sep; 140(3):331-4. PubMed ID: 16934588
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver Transplant for Cholangiocarcinoma.
    Zamora-Valdes D; Heimbach JK
    Gastroenterol Clin North Am; 2018 Jun; 47(2):267-280. PubMed ID: 29735023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioembolization with yttrium as neoadjuvant therapy in initially unresectable intrahepatic cholangiocarcinoma.
    Villalabeitia Ateca I; Prieto Calvo M; Martínez de la Cuesta A; Rodríguez-Fraile M; Gastaca Mateo M
    Cir Esp (Engl Ed); 2023 Feb; 101(2):143-145. PubMed ID: 36064166
    [No Abstract]   [Full Text] [Related]  

  • 8. Discussion of: Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
    Am J Surg; 2018 Mar; 215(3):471. PubMed ID: 29502671
    [No Abstract]   [Full Text] [Related]  

  • 9. Transplantation for cholangiocarcinoma: when and for whom?
    Rea DJ; Rosen CB; Nagorney DM; Heimbach JK; Gores GJ
    Surg Oncol Clin N Am; 2009 Apr; 18(2):325-37, ix. PubMed ID: 19306815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma.
    Rana A; Hong JC
    Curr Opin Gastroenterol; 2012 May; 28(3):258-65. PubMed ID: 22333563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy].
    Yamada K; Sakamoto K; Tamesa T; Matsui H; Shindo Y; Tokumitsu Y; Hashimoto N; Iida M; Maeda Y; Tokuhisa Y; Suzuki N; Yoshimura K; Ueno T; Takahashi M; Shibuya K; Kondo T; Oka M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1756-8. PubMed ID: 24393912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of neoadjuvant chemoradiation therapy for clinical Stage II cholangiocarcinoma as a preoperative diagnosis].
    Nakagawa K; Katayose Y; Unno M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1945-7. PubMed ID: 23267938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation for cholangiocarcinoma.
    Masuoka HC; Rosen CB
    Clin Liver Dis; 2011 Nov; 15(4):699-715. PubMed ID: 22032524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
    Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
    Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.
    Lee KB
    Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
    Hong JC; Jones CM; Duffy JP; Petrowsky H; Farmer DG; French S; Finn R; Durazo FA; Saab S; Tong MJ; Hiatt JR; Busuttil RW
    Arch Surg; 2011 Jun; 146(6):683-9. PubMed ID: 21690444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma.
    Turaga KK; Tsai S; Wiebe LA; Evans DB; Gamblin TC
    Ann Surg Oncol; 2013 Apr; 20(4):1230-9. PubMed ID: 23064778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Tool for Patient-Focused Care Regarding Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma.
    Cools KS; Glazer ES
    Ann Surg Oncol; 2021 Apr; 28(4):1874-1875. PubMed ID: 33417116
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Role of Neoadjuvant Therapy in Surgically Resectable Intrahepatic Cholangiocarcinoma.
    Mason MC; Tran Cao HS
    Ann Surg Oncol; 2021 Oct; 28(11):6736-6737. PubMed ID: 33452608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.